Pneumonia is more frequent in the elderly and results in higher morbidity and mortality. Although the incidence of pneumonia increases with age, from 1 per 1,000 to 12 per 1,000 persons over age 75 years, comorbid medical illnesses and host defense impairments (especially heart disease, chronic obstructive pulmonary disease, and aspiration risk) are independent risk factors. The microbial etiology of pneumonia in the healthy elderly is similar to that in younger patients but shifts toward a more gram-negative and opportunistic flora with increasing age and severity of concomitant medical illness. The choice of antimicrobial therapy must be based on risk stratification (age, medical illnesses, and severity of presentation). Guidelines based on these principles will be reviewed. Pneumococcal and influenza vaccination reduce the risk of death due to pneumonia and are costeffective preventative strategies.
The United States, along with the rest of the developed per 1,000 persons in the general population but increases to 12 world, is undergoing extraordinary demographic change. Elper 1,000 persons for those over age 75 years and to 33 per derly patients constitute an ever-increasing proportion of the 1,000 residents for those in chronic care facilities. The crude population. Lower respiratory tract infections, along with semortality rate for influenza and pneumonia published by the vere tracheobronchitis, have traditionally been recognized as Centers for Disease Control and Prevention (CDC) was 32 per problems that particularly afflict older individuals. As the popu-100,000 population in 1994. The elderly are more likely to be lation of those over age 65 years moves from its current level dependent and require care in a chronic care nursing facility, of 12% to close to 25% in the year 2050, respiratory tract where the prevalence of pneumonia may be as high as 2% infection will assume a greater degree of importance to the and mortality as high as 32% [6] . In this setting, the clinical overall public health [1] . The purpose of this review is to manifestations of lower respiratory tract infection may overlap highlight the unique features and barriers to improved outcomes those of what has been traditionally viewed as hospital-acquired of pneumonia in the elderly as well as to highlight potential infection [1, 6, 7] . In chronic care facilities, the increasing solutions. The focus is on diagnostic and therapeutic considerapopulation of patients who are chronically mechanically ventitions of pneumonia acquired in the community rather than lated adds a new dimension to the problem of prevention, of nursing home pneumonia, which has many similarities to diagnosis, and treatment. These patients are chronically colonosocomial lower respiratory tract infection.
nized and have a higher risk for recurrent pneumonia. What is the nature of the enhanced risk of lower respiratory tract infection faced by older individuals [4, 8 -10] ? First, aging Problem Defined itself results in reduced lung elasticity and respiratory muscle There is little doubt that death is more likely (threefold to strength (both inspiratory and expiratory), with potential impact fivefold) to be the outcome of pneumonia in elderly individuals on secretion clearance after aspiration. More important is the than it is in young adults. This observation must be viewed in cumulative effect of multiple medical illnesses, which continthe context of the host-pathogen interaction [1] . Risks increase ues to add ''baggage'' to host defense impairment. In one with age and associated medical illness. Those over age 65 study, independently defined risk factors for community-acyears account for ú50% of pneumonia cases and 90% of all quired pneumonia included alcoholism (RR, 9.0), asthma (RR, deaths due to lower respiratory tract infection [2 -5] . The over-4.2), immunosuppression (RR, 3.1), and heart disease (RR, 1.9) all rate of pneumonia requiring hospitalization is as low as 1 [4] . Chronic obstructive pulmonary disease (COPD), congestive heart failure, malignancy, and neurological impairment are consistently reported in association with pneumonia requiring hospitalization [4, 11] . With increasing age, it becomes more
This article is part of the Infectious Diseases series of papers presented at the Hartford Foundation -sponsored symposium entitled ''Integrating Geriatlikely that more than one significant medical illness will be rics into Rheumatology, Infectious Diseases, and Immunology'' that was held present. The older, more debilitated the patient, the more likely the fungi)
classic pneumonia syndrome will be incompletely expressed [1, 9, 23] . The characteristics identified by most commonly employed techniques of physical diagnosis (decreased breath tion, which has been identified as an independent risk factor sounds, crackles, and egophony) are poor and must be comfor pneumonia in older individuals, integrates many of the bined with vital-sign abnormalities if specificity is to be imabove predispositions and serves as a potentially modifiable proved [23] . While fever is less commonly observed, confusion problem [11] . In addition, the development of medical illness and delirium are more common. Tachypnea and tachycardia enhances the likelihood that an iatrogenic cause will contribute may be the only findings heralding the onset of lower respirato an inability to contain local respiratory tract pathogens. The tory tract infection. Radiological examination, the reference more frequent use of antibiotics in this setting had led to a standard for diagnosis of pneumonia, has limited specificity, high rate of invasive infection with resistant organisms. Age, as illnesses such as COPD, heart failure, and malignancy obhospitalization, and duration of antibiotic use have been recogscure the interpretation of classic alveolar and interstitial infilnized as increasing the likelihood of penicillin-resistant Streptrates. This has been a particular problem for the critically ill tococcus pneumoniae infection [12] . The impact of heart failure and ventilator-dependent patient [24 -27] . on the risk of pneumonia is likely multifactorial. It has been Traditionally, clinicians have relied on gram staining and attributed in part to enhanced bacterial growth and impaired culture of expectorated sputum to establish microbial etiology. clearance related to pulmonary edema fluid.
Since the old and seriously ill often produce little sputum and cough ineffectively, this approach may not be applicable or cost effective, given the limited specificity of culture and sensiPathogens tivity of gram staining [22, 23] . The role of blood cultures remains controversial, and although culture is part of ''the The etiology of pneumonia in the healthy elderly parallels usual care standard,'' its result does not usually change treatthat in younger individuals and shifts as a function of deterioratment plan or outcome. Given the frequency and severity of ing functional status, increased severity, and numbers of counderlying medical illness, the risks of invasive diagnostic apexisting medical illnesses (table 1) .
proaches using bronchoscopy (with quantitative culture) or neeThe elderly are more likely to be colonized with enteric dle aspiration may be too high to warrant routine application. gram-negative rods, especially if functional status, duration of This has led to widespread empirical antibiotic therapy (with hospitalization, and concomitant medical illness are factors its attendant cost) and, consequently, emergence of resistant [13 -15] . An increasing incidence of gram-negative-rod and Staphylococcus aureus gram-negative rods and S. pneumoniae. mixed pneumonia is observed in community-, nursing home-, While one may question whether age should be a reason for and hospital-acquired lower respiratory tract infection. Comaltering the diagnostic approach, careful analysis suggests it munity-acquired pneumonia due to Pseudomonas aeruginosa probably is, especially for debilitated patients near the end of may be more common with aging and structural lung disease. In the healthy elderly residing in the community, the spectrum life.
/ 9c64$$ap57 03-15-99 08:32:42 cida UC: CID Where Should the Elderly be Treated? coccal activity) can be part of the initial management strategy for both outpatient pneumonia (alone) or inpatient pneumonia Innovative programs are attempting to meet patient demand (combination) in elderly patients. In addition, new information for treatment in a nonhospital setting. In general, most patients suggests that a switch or step-down in therapy after a short who believe they are not critically ill prefer treatment at home. period or intravenous therapy may be accomplished even in Thus, the traditional clinical practice of management within elderly residents of chronic care facilities [31] . Enhanced biothe hospital for all patients over age 65 years may be modified availability of newly available antibiotics may facilitate home on the basis of risk factors, severity of illness, virulence of management with oral agents throughout the course of treatpathogens, age, and comorbidities. Recent paradigms relying ment. on prospectively validated scoring systems permit better triage of patients to appropriate settings of care [27, 28] . Those over Preventive Strategies 75 years of age presenting with high-risk conditions (organ Even though vaccination with currently available preparadysfunction, respiratory failure, or shock) or medical illnesses tions may produce an incomplete antibody response in the frail (diabetes, chronic renal failure, COPD, congestive heart failure, elderly, efficacy of both pneumococcal and influenza vaccinaor stroke) should be managed within the hospital setting. Outtion is estimated to be at least 50% [32 -34] . Recent studies come studies, however, have not validated the efficacy of these have documented that influenza vaccination reduced the overall practices. Unique to very elderly or infirm patients is the need number of hospitalizations. Admission for pneumonia and conto ensure adequate monitoring and compliance with the medicagestive heart failure was also decreased [32 -35] . Use of the tion regimen. When this is not possible in the home, access to 23-valent pneumococcal vaccine has been demonstrated to enhospital care is important.
hance prevention of pneumonia, in comparison with the effect of influenza vaccination alone [35] . Despite these encouraging Therapeutic Paradigms: How Different are the Elderly?
statistics, in 1995 compliance with current recommendations was õ60% for influenza [36] and õ40% for pneumococcal The older and more infirm the patient, the more likely theravaccination [35] . Because of the minimal side effects and wanpeutic difficulties will be encountered. Declining creatinine ing immunity, the CDC has recently recommended that this clearance poses an added risk of drug toxicity when renally vaccine be administered every 5 years rather than as a single excreted antibiotics (i.e., aminoglycosides) are administered.
lifetime dose as previously advised. The application of molecuIn addition, dementia may result in uncertain compliance with lar biology to vaccine technology may improve the activity of medication regimens. The high cost of any antibiotics must vaccines currently available [37] . also be factored into the likelihood that low-or fixed-income patients will complete antibiotic regimens. Summary A number of recent consensus conferences have sought to establish a rational approach to initial management of pneumo-
The importance of pneumonia in the elderly is rising and increases both the clinical challenges as well as the potential nia. The 1993 clinical practice guidelines of the American Thoracic Society [17] and guidelines published in 1998 by the for creative solutions. The dramatic increase in frail elderly persons and consequent requirement for dependent care creates Infectious Diseases Society of America [16] suggested empirical therapy based on risk factors, age, and triage location a new clinical context for pneumonia in that it is more difficult to both recognize and treat, thus consuming more resources (home, hospital, or intensive care unit). Recommendations for those over age 60 years with more than one comorbidity include in the process. Solutions will have to improve access to and compliance with currently available preventive and therapeutic therapy with a second-or third-generation cephalosporin (when they are hospitalized), with an added macrolide agent if atypical regimens while permitting more treatment at home. New technologies should permit better outcomes through more effective pathogens are suspected on the basis of local epidemiology. A recently published prospective registry study evaluated outdiagnosis and better-focused treatment, thereby eliminating the current empirical approach with attendant increased duration comes for outpatients and showed that the use of macrolide antibiotics (erythromycin, clarithromycin, or azithromycin) of therapy and microbial resistance. Immune modulation by enhancers like granulocyte colony stimulating factor and moduwas associated with improved outcomes (at lower cost) for elderly patients, even those with associated comorbidity [29] .
lators like anticytokines may even permit dramatic reductions in the duration of therapy, with better outcomes. The coming Newly available expanded-spectrum quinolone antibiotics are active against penicillin-resistant S. pneumoniae and Legiodecade will see us demographically challenged. We expect our therapeutic initiatives will keep pace. nella species and, when used as single agents in hospitalized patients, produce outcomes comparable to those with standard cephalosporin/erythromycin combinations [30] . Quinolone 
